Refurbished Medical Equipment Market - Global Forecast To 2029
商品番号 : SMB-71600
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年1月 |
| ページ数 | 412 |
| 図表数 | 489 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The Refurbished medical equipment market is projected to reach USD 24.41 Billion by 2029 from USD 16.93 in 2024, growing at a CAGR of 7.6% during the forecast period.
再生医療機器市場は、2024年の16.93米ドルから2029年までに244億1,000万米ドルに達すると予測されており、予測期間中に7.6%のCAGRで成長します。
The market is growing due to numerous factors.Increasing cases of infectious diseases, and regular advancements in Refurbished medical equipment drives this market. Rising expenditure in research and development and increase in application of biomarker profiling to detect diseases are other factors. Additionally, the market growth is affected by inclusion of Refurbished medical equipment with artificial intelligence.
市場はさまざまな要因により成長しています。感染症の症例の増加と再生医療機器の定期的な進歩がこの市場を推進しています。研究開発への支出の増加と、疾患を検出するためのバイオマーカープロファイリングの応用の増加も他の要因です。さらに、市場の成長は、人工知能を備えた再生医療機器の導入によって影響を受けます。
“Medical imaging equipment to account for largest market share in 2023.”
A market is being formed for the refurbished medical imaging equipment owing to the increased sectored investments in private healthcare and emerging health infrastructures in developing economies. This makes refurbished systems like CT and X-ray machines affordable for new hospitals within emerging markets. Multi-dimensional forces such as economic elements, technological advancement, and regulatory frameworks encourage the growth of refurbished medical imaging equipment markets globally. Organizations dealing in refurbished medical imaging adhere to many regulations since these should guarantee that they meet or exceed the industry standards. Siemens Healthineers and GE Healthcare, for instance, provides refurbished MRI systems and CT scanners with warranties and certifications.
“Hospitals to hold largest share in the market.”
Various significant factors are propelling the growth of hospitals in the refurbished medical equipment industry. Numerous causes like economic pressures, technological advancements, and healthcare-related factors have encouraged the global growth of refurbished medical equipment in hospitals and surgical centers. Some of these causes include rising prices for new medical devices, the increasing requirement for cost-effective health-care solutions, and improvements in refurbishment methods. A good example of commonly utilized ultrasound windows is in rural areas or areas with low budgets. They provide high performance while being cheaper than new equipment; thus, they ensure diagnostic services continue even at low-resource settings.
“North America to register largest share in 2023.”
The largest share was hold by North America in 2023. North America comprise US and Canada.
Reduced costs are one of the most major factors attracting North America towards refurbished medical equipment. Genuinely refurbished equipment serves as a shake quality alternative to new devices, enabling hospitals to make do even with very restricted budgets. Above all, pressure from the government for sustainability and the reduction of electronic waste in North America adds importance to refurbishing medical equipment. It promises to nullify the environmental impact of thrown-up devices and at the same time promote circular economies. In North America, refurbished medical equipment stands under very stringent regulatory requirements (like FDA in the U.S.). The quality and safety assured make healthcare providers much more confident in purchasing refurbished devices. As well, hospitals and clinics grow their medical arms without making huge financial outlays for the refurbished option to fulfill the high demand for urine ultrasound machines in North America.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3– 20%
- By Designation: C-level– 35%, Director-level–25%, and Others–40%
- By Region: North America–40%, Europe-30%, Asia Pacific–20%, Latin America – 5%, Middle East & Africa- 5%
Prominent players in the Refurbished medical equipment market include GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Block Imaging International,Inc. (US), Canon Medical Systems Corp. (Japan), Soma Technology, Inc. (US), and Avante Health Solutions (US), Mindray Medical International (China), Dragerwerk AG & Co. KGAA (Germany), Whittemore Enterprises (U.S.), Stryker (US), Directmed Parts & Services (US), Medline Industries (U.S.), Traco Medical (U.S.), Nihon Kohden Corporation (Japan), Master Medical Equipment (U.S.), and Everx Pvt. Ltd. (US).
Research Coverage
The report comprise segmentation that includes end users, products, applications, and geographic regions. It also discusses the key drivers, restraints, opportunities, and challenges affecting the growth of the Refurbished medical equipment market. The research offers stakeholders an assessment of market potential and challenges, with a focus on key players and competitive landscapes. Additionally, micromarkets are assessed according to their overall to the refurbished medical equipment sector, growth patterns, and potential. The analysis estimates increase in market segment revenues, focusing on five regions.
Key Benefits of Buying the Report:
This research aids new and existing players in the Refurbished medical equipment market to assess the sustainability of their investments by offering detailed information. It offers a dataset to assist in making key decisions. The main advantage of this report includes risk evaluation and offering direction for investment decisions. Market segmentation as per the end-users and geographical areas is offered in the study, that provides analysis and insights. It also provides trends, obstacles, opportunities, and drivers, giving stakeholders the information they need to make strategic decisions.
The report provides the insights on the following pointers:
- Analysis of the key drivers, restraints, opportunities, and challenges impacting the Refurbished medical equipment market growth: rise in prevalence of chronic diseases, cost efficiency as compared to new medical equipment; negative perception for refurbished product quality; updated technology with software integration and regulatory support helps refurbished medical equipment to grow in the market.
- Product Development/Innovation: Overview of technologies, research & development ventures and launch of innovative product & service for the refurbished medical equipment industry.
- Market Development: Details related to profitable markets: this research discussees the Refurbished medical equipment business in numerous regions.
- Market Diversification: Detailed understanding of advanced products, unexplored areas, latest developments, and investment in the market.
- Competitive Assessment: Detailed analysis of market share, services and products offered and key strategies adopted by prominent players such as GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Avante Health Solutions (US), Soma Technology, Inc. (US) and Canon Medical Systems Coproration(Japan).
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 SEGMENTS COVERED & GEOGRAPHICAL SPREAD 35
1.3.2 INCLUSIONS & EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.3.4 CURRENCY CONSIDERED 37
1.4 MARKET STAKEHOLDERS 38
1.5 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
2.2 RESEARCH DESIGN 40
2.2.1 SECONDARY RESEARCH 40
2.2.1.1 Key secondary sources 40
2.2.1.2 Key objectives of secondary research 41
2.2.1.3 Key data from secondary sources 42
2.2.2 PRIMARY RESEARCH 42
2.2.2.1 Key primary sources 43
2.2.2.2 Key objectives of primary research 43
2.2.2.3 Key industry insights 44
2.2.2.4 Breakdown of primaries 44
2.3 MARKET SIZE ESTIMATION 45
2.3.1 BOTTOM-UP APPROACH 46
2.3.1.1 Company revenue estimation approach 47
2.3.1.2 Customer-based market estimation 47
2.3.2 TOP-DOWN APPROACH 48
2.3.2.1 Primary interviews 49
2.4 MARKET GROWTH FORECAST 49
2.5 DATA TRIANGULATION 50
2.6 MARKET SHARE ASSESSMENT 51
2.7 STUDY ASSUMPTIONS 51
2.8 GROWTH ASSUMPTIONS 51
2.9 RISK ASSESSMENT 53
2.10 RESEARCH LIMITATIONS 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 60
4.1 REFURBISHED MEDICAL EQUIPMENT MARKET OVERVIEW 60
4.2 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 61
4.3 REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY AND
END USER, 2023 (USD MILLION) 62
4.4 GEOGRAPHIC SNAPSHOT OF REFURBISHED MEDICAL EQUIPMENT MARKET 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
5.2.1 DRIVERS 65
5.2.1.1 Increased need for affordable and advanced
diagnostic imaging equipment 65
5.2.1.2 Better warranties and service agreements for refurbished equipment 65
5.2.1.3 Increased focus on environmental sustainability in healthcare sector 66
5.2.1.4 Rising healthcare costs and need for cost-saving alternatives 66
5.2.2 RESTRAINTS 67
5.2.2.1 Lesser reliability in high-regulated sectors and lack of standardized refurbishment processes 67
5.2.2.2 Availability of cost-effective new medical equipment 67
5.2.3 OPPORTUNITIES 68
5.2.3.1 Increased acceptability of refurbished equipment by large hospitals
and healthcare systems 68
5.2.3.2 Expansion of online marketplaces and global logistics networks 68
5.2.4 CHALLENGES 69
5.2.4.1 Lack of uniform refurbishment standards for medical equipment 69
5.2.4.2 Rapid innovation in medical technology 69
5.3 VALUE CHAIN ANALYSIS 70
5.4 PORTER’S FIVE FORCES ANALYSIS 72
5.4.1 THREAT OF NEW ENTRANTS 73
5.4.2 THREAT OF SUBSTITUTES 73
5.4.3 BARGAINING POWER OF SUPPLIERS 73
5.4.4 BARGAINING POWER OF BUYERS 73
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.5 KEY STAKEHOLDERS & BUYING CRITERIA 74
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
5.5.2 KEY BUYING CRITERIA 75
5.6 PATENT ANALYSIS 76
5.6.1 LIST OF MAJOR PATENTS 77
5.7 KEY CONFERENCES & EVENTS, 2024–2026 79
5.8 TRADE DATA ANALYSIS 80
5.8.1 IMPORT DATA FOR HS CODE 9018 80
5.8.2 EXPORT DATA FOR HS CODE 9018 81
5.9 PRICING ANALYSIS 81
5.9.1 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL EQUIPMENT,
BY REGION, 2021–2023 81
5.9.2 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL IMAGING EQUIPMENT, BY PRODUCT, 2021–2023 85
5.9.3 AVERAGE SELLING PRICE OF REFURBISHED MEDICAL EQUIPMENT,
BY KEY PLAYER, 2023 88
5.10 UNMET NEEDS & KEY PAIN POINTS 89
5.11 ECOSYSTEM ANALYSIS 90
5.12 SUPPLY CHAIN ANALYSIS 91
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93
5.14 TECHNOLOGY ANALYSIS 93
5.14.1 KEY TECHNOLOGIES 93
5.14.1.1 Portable and point-of-care medical devices 93
5.14.1.2 Diagnostic imaging systems 94
5.14.1.3 Laboratory, surgical, and therapeutic equipment 94
5.14.2 COMPLEMENTARY TECHNOLOGIES 94
5.14.2.1 AI-powered predictive analytics 94
5.14.2.2 Digital connectivity and telemedicine technologies 95
5.14.2.3 Remote monitoring technologies 95
5.14.3 ADJACENT TECHNOLOGIES 95
5.14.3.1 Robotics and automation technologies 95
5.15 REGULATORY LANDSCAPE 96
5.15.1 REGULATORY FRAMEWORK 96
5.15.1.1 North America 96
5.15.1.1.1 US 96
5.15.1.1.2 Canada 96
5.15.2 EUROPE 97
5.15.3 ASIA PACIFIC 98
5.15.3.1 Japan 98
5.15.3.2 China 99
5.15.3.3 India 99
5.15.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
5.16 INVESTMENT & FUNDING SCENARIO 102
5.17 REIMBURSEMENT SCENARIO ANALYSIS 104
5.18 IMPACT OF AI/GEN AI ON REFURBISHED MEDICAL EQUIPMENT MARKET 105
6 REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT 106
6.1 INTRODUCTION 107
6.2 MEDICAL IMAGING EQUIPMENT 108
6.2.1 CT SCANNERS 113
6.2.1.1 Cost-effectiveness and favorable government regulations to
propel segment growth 113
6.2.2 MRI MACHINES 116
6.2.2.1 Need to reduce healthcare costs and increase focus on technological advancements to aid market growth 116
6.2.3 X-RAY MACHINES 119
6.2.3.1 Availability of flexible leasing and financing options to spur adoption 119
6.2.4 NUCLEAR IMAGING SYSTEMS 122
6.2.4.1 Public-private investments for purchasing new high-end nuclear imaging systems to limit market growth 122
6.2.5 ULTRASOUND SYSTEMS 125
6.2.5.1 Economic downturn and decreased reimbursement for new equipment in developed countries to drive market 125
6.2.6 PET/SPECT SYSTEMS 128
6.2.6.1 Reduced electronic wastage to support sustainability
initiatives in healthcare 128
6.2.7 MAMMOGRAPHY SYSTEMS 131
6.2.7.1 Rising number of breast cancer cases and decreasing cost of refurbished mammography systems to augment market growth 131
6.3 OPERATING ROOM & SURGICAL EQUIPMENT 135
6.3.1 ANESTHESIA MACHINES 139
6.3.1.1 Long waiting times for new equipment delivery to support segment growth 139
6.3.2 ELECTROSURGICAL UNITS 141
6.3.2.1 Hospital budget limitations and focus on minimally invasive surgeries to promote segment growth 141
6.3.3 OPERATING ROOM TABLES & LIGHTS 144
6.3.3.1 Low financial capabilities of healthcare organizations in emerging economies to boost adoption 144
6.3.4 SURGICAL DISPLAYS 147
6.3.4.1 High fluctuation in raw material and display panel pricing to propel adoption in healthcare settings 147
6.3.5 OTHER OPERATING ROOM & SURGICAL EQUIPMENT 151
6.4 PATIENT MONITORS 154
6.4.1 MULTIPARAMETER MONITORS 159
6.4.1.1 Increased use of home patient monitoring and low prices compared to mid- and high-acuity monitors to drive segment 159
6.4.2 FETAL MONITORS 162
6.4.2.1 Increasing prevalence of obstetric complications and preterm births to fuel adoption 162
6.4.3 ELECTROCARDIOGRAPHY DEVICES 166
6.4.3.1 Wide applications of ECG devices in cardiovascular diseases
to drive market 166
6.4.4 PULSE OXIMETERS 169
6.4.4.1 Introduction of low-cost single-use pulse oximeters to limit market growth 169
6.4.5 CARDIAC MONITORS 173
6.4.5.1 Need to reduce healthcare costs and high demand for home monitoring to support market growth 173
6.4.6 NON-INVASIVE BLOOD PRESSURE MONITORS 176
6.4.6.1 Growing health awareness and increasing incidence of cardiovascular diseases to propel segment growth 176
6.4.7 OTHER PATIENT MONITORS 179
6.5 CARDIOLOGY EQUIPMENT 183
6.5.1 DEFIBRILLATORS 187
6.5.1.1 Increasing prevalence of CVDs in low-income countries to drive adoption of refurbished defibrillators 187
6.5.2 HEART-LUNG MACHINES 190
6.5.2.1 Rising number of cardiac surgeries to support segment growth 190
6.5.3 OTHER CARDIOLOGY EQUIPMENT 193
6.6 UROLOGY EQUIPMENT 197
6.6.1 DIALYSIS MACHINES 200
6.6.1.1 Development of low-cost dialysis products to limit market growth 200
6.6.2 LITHOTRIPSY DEVICES 203
6.6.2.1 Increasing cases of kidney and ureteric stones to increase demand for refurbished lithotripsy devices 203
6.7 NEUROLOGY EQUIPMENT 206
6.7.1 EMG MACHINES 211
6.7.1.1 Use of EMG nerve monitoring for intraoperative applications to
fuel segment growth 211
6.7.2 EEG MACHINES 213
6.7.2.1 Reimbursement cuts to increase adoption of refurbished EEG machines 213
6.8 INTENSIVE CARE EQUIPMENT 216
6.8.1 VENTILATORS 221
6.8.1.1 Improved refurbishment techniques for upgrading used
ventilators to drive growth 221
6.8.2 INFANT INCUBATORS & WARMERS 224
6.8.2.1 High global birthrate and increasing number of neonates requiring additional medical intervention to fuel segment growth 224
6.9 INTRAVENOUS THERAPY SYSTEMS 228
6.9.1 INCREASING NUMBER OF SURGICAL PROCEDURES AND FREQUENT
PRODUCT RECALLS TO SUPPORT MARKET GROWTH 228
6.10 ENDOSCOPY EQUIPMENT 232
6.10.1 RISING DEMAND FOR ENDOSCOPY IN DETECTING CHRONIC DISEASES TO SUPPORT MARKET GROWTH 232
6.11 OTHER MEDICAL EQUIPMENT 236
7 REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION 241
7.1 INTRODUCTION 242
7.2 CARDIOLOGY DIAGNOSTIC APPLICATIONS 244
7.2.1 INCREASING INCIDENCE OF CARDIOVASCULAR AND CARDIO-PULMONARY DISORDERS TO DRIVE MARKET 244
7.3 UROLOGY DIAGNOSTIC APPLICATIONS 245
7.3.1 LOW BUDGET AVAILABILITY FOR PROCURING NEW UROLOGICAL
EQUIPMENT TO AID MARKET GROWTH 245
7.4 NEUROLOGY DIAGNOSTIC APPLICATIONS 246
7.4.1 BUDGET CONSTRAINTS TO INCREASE DEMAND FOR REFURBISHED MEDICAL EQUIPMENT AND STRATEGIC RESOURCE ALLOCATION 246
7.5 ORTHOPEDIC DIAGNOSTIC APPLICATIONS 247
7.5.1 GROWING GERIATRIC POPULATION AND RISING INCIDENCE OF TARGET DISEASES TO AID MARKET GROWTH 247
7.6 PHYSIOLOGY DIAGNOSTIC APPLICATIONS 248
7.6.1 RISING AWARENESS OF EARLY DISEASE DIAGNOSIS AND GROWING FOCUS ON HEALTHY LIFESTYLES TO AUGMENT MARKET GROWTH 248
7.7 EMERGENCY MEDICINE DIAGNOSTIC APPLICATIONS 249
7.7.1 INCREASING NUMBER OF NEONATES IN INTENSIVE CARE UNITS TO
PROPEL MARKET GROWTH 249
7.8 ONCOLOGY DIAGNOSTIC APPLICATIONS 250
7.8.1 HIGH INCIDENCE OF MALIGNANCIES AND INCREASED COST OF NEW MEDICAL IMAGING EQUIPMENT TO FUEL MARKET GROWTH 250
7.9 OB/GYNECOLOGY DIAGNOSTIC APPLICATIONS 251
7.9.1 INCREASING NUMBER OF MATERNITY CENTERS AND DIAGNOSTIC CLINICS TO SUPPORT MARKET GROWTH 251
7.10 OTHER DIAGNOSTIC APPLICATIONS 251
7.11 CARDIOLOGY THERAPEUTIC APPLICATIONS 252
7.11.1 LOW COST OF REFURBISHED EQUIPMENT AND HIGH-QUALITY CONTROL MEASURES BY OEMS TO DRIVE MARKET 252
7.12 UROLOGY THERAPEUTIC APPLICATIONS 253
7.12.1 BUDGETARY CONSTRAINTS IN PROCURING NEW EQUIPMENT TO
BOOST MARKET GROWTH 253
7.13 NEUROLOGY THERAPEUTIC APPLICATIONS 254
7.13.1 GROWING DEMAND FOR REFURBISHED ELECTROSURGERY AND SURGICAL EQUIPMENT TO PROPEL MARKET GROWTH 254
7.14 ORTHOPEDIC THERAPEUTIC APPLICATIONS 255
7.14.1 GROWING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET 255
7.15 PHYSIOLOGY THERAPEUTIC APPLICATIONS 256
7.15.1 DEARTH OF SKILLED SPECIALISTS IN EMERGING ECONOMIES TO
LIMIT MARKET GROWTH 256
7.16 EMERGENCY MEDICINE THERAPEUTIC APPLICATIONS 257
7.16.1 IMPROVED CRITICAL CARE INFRASTRUCTURE AND NEED FOR MORE ESSENTIAL CARE EQUIPMENT TO AUGMENT MARKET GROWTH 257
7.17 ONCOLOGY THERAPEUTIC APPLICATIONS 258
7.17.1 GROWING NUMBER OF NON-INVASIVE AND INTERVENTIONAL CANCER TREATMENT PROCEDURES TO AID MARKET SEGMENT 258
7.18 OB/GYNECOLOGY THERAPEUTIC APPLICATIONS 259
7.18.1 GROWING AWARENESS OF MATERNITY CARE IN EMERGING ECONOMIES TO
DRIVE MARKET GROWTH 259
7.19 OTHER THERAPEUTIC APPLICATIONS 260
8 REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER 261
8.1 INTRODUCTION 262
8.2 HOSPITALS 262
8.2.1 REFURBISHED EQUIPMENT TO IMPROVE HEALTHCARE INFRASTRUCTURE WITHOUT HIGH COST OF NEW DEVICES 262
8.3 DIAGNOSTIC IMAGING CENTERS 263
8.3.1 INCREASED NEED FOR IMAGING FOR EARLY DETECTION AND TREATMENT PLANNING TO SPUR MARKET GROWTH 263
8.4 ACADEMIC & GOVERNMENT ORGANIZATIONS 264
8.4.1 REFURBISHED EQUIPMENT TO OFFER FINANCIALLY VIABLE ALTERNATIVE AND REDUCE ELECTRONIC WASTAGE 264
8.5 AMBULATORY CARE CENTERS 265
8.5.1 INCREASING PREFERENCE FOR OUTPATIENT PROCEDURES TO
PROPEL MARKET GROWTH 265
8.6 OTHER END USERS 266
9 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION 268
9.1 INTRODUCTION 269
9.2 NORTH AMERICA 269
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 270
9.2.2 US 274
9.2.2.1 US to dominate refurbished medical equipment market
during forecast period 274
9.2.3 CANADA 276
9.2.3.1 Budgetary constraints in hospitals and high demand for imaging procedures to aid adoption of refurbished medical equipment 276
9.3 EUROPE 277
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 278
9.3.2 GERMANY 282
9.3.2.1 Well-established pharmaceutical and R&D industry to
propel market growth 282
9.3.3 FRANCE 284
9.3.3.1 Increasing government pressure to reduce healthcare costs to
support market growth 284
9.3.4 UK 285
9.3.4.1 Rising preference for new equipment due to better safety and
compliance to limit market 285
9.3.5 ITALY 287
9.3.5.1 Supportive government policies and focus on value-based healthcare system to boost market growth 287
9.3.6 SPAIN 288
9.3.6.1 Technological advancements and improved healthcare infrastructure to aid market growth 288
9.3.7 REST OF EUROPE 290
9.4 ASIA PACIFIC 291
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 291
9.4.2 CHINA 297
9.4.2.1 Rapidly changing healthcare infrastructure and favorable government incentives to fuel market growth 297
9.4.3 JAPAN 299
9.4.3.1 High geriatric population and favorable health insurance system to propel market growth 299
9.4.4 INDIA 300
9.4.4.1 Low cost of refurbished equipment and need for alternatives to healthcare service to support market growth 300
9.4.5 AUSTRALIA 302
9.4.5.1 Preference for new equipment by government healthcare organizations to limit demand for refurbished medical equipment 302
9.4.6 SOUTH KOREA 303
9.4.6.1 Increased insurance coverage and free trade agreements with
US to support market growth 303
9.4.7 REST OF ASIA PACIFIC 305
9.5 LATIN AMERICA 305
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 306
9.5.2 BRAZIL 309
9.5.2.1 Growing disease burden and rising awareness about advanced
diagnostic and treatment procedures to support market growth 309
9.5.3 MEXICO 311
9.5.3.1 Favorable investment scenario for refurbished medical device manufacturers to drive market 311
9.5.4 REST OF LATIN AMERICA 312
9.6 MIDDLE EAST & AFRICA 313
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 314
9.6.2 GCC COUNTRIES 317
9.6.2.1 Advancements in healthcare infrastructure and increased focus on personalized medicines to fuel market growth 317
9.6.3 REST OF MIDDLE EAST & AFRICA 318
10 COMPETITIVE LANDSCAPE 320
10.1 INTRODUCTION 320
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 320
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
REFURBISHED MEDICAL EQUIPMENT MARKET 320
10.3 REVENUE ANALYSIS, 2019–2023 322
10.4 MARKET SHARE ANALYSIS, 2023 323
10.4.1 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET SHARE,
BY KEY PLAYER, 2023 323
10.4.2 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET SHARE,
BY KEY PLAYER, 2023 323
10.4.3 REFURBISHED PATIENT MONITORS MARKET SHARE, BY KEY PLAYER, 2023 324
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 326
10.5.1 STARS 326
10.5.2 EMERGING LEADERS 326
10.5.3 PERVASIVE PLAYERS 326
10.5.4 PARTICIPANTS 326
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 328
10.5.5.1 Company footprint 328
10.5.5.2 Region footprint 329
10.5.5.3 Product footprint 330
10.5.5.4 Application footprint 331
10.5.5.5 End-user footprint 332
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 333
10.6.1 PROGRESSIVE COMPANIES 333
10.6.2 RESPONSIVE COMPANIES 333
10.6.3 DYNAMIC COMPANIES 333
10.6.4 STARTING BLOCKS 333
10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023 335
10.7 COMPANY VALUATION & FINANCIAL METRICS 337
10.8 PRODUCT/BRAND COMPARISON 338
10.9 COMPETITIVE SCENARIO 339
10.9.1 PRODUCT LAUNCHES 339
10.9.2 DEALS 340
11 COMPANY PROFILES 341
11.1 KEY PLAYERS 341
11.1.1 GE HEALTHCARE 341
11.1.1.1 Business overview 341
11.1.1.2 Products offered 343
11.1.1.3 Recent developments 345
11.1.1.3.1 Product launches 345
11.1.1.3.2 Deals 345
11.1.1.3.3 Expansions 345
11.1.1.4 MnM view 346
11.1.1.4.1 Key strengths 346
11.1.1.4.2 Strategic choices 346
11.1.1.4.3 Weaknesses & competitive threats 346
11.1.2 PHILIPS HEALTHCARE 347
11.1.2.1 Business overview 347
11.1.2.2 Products offered 348
11.1.2.3 Recent developments 350
11.1.2.3.1 Product launches 350
11.1.2.3.2 Deals 351
11.1.2.3.3 Other developments 351
11.1.2.4 MnM view 351
11.1.2.4.1 Key strengths 351
11.1.2.4.2 Strategic choices 352
11.1.2.4.3 Weaknesses & competitive threats 352
11.1.3 SIEMENS HEALTHINEERS AG 353
11.1.3.1 Business overview 353
11.1.3.2 Products offered 354
11.1.3.3 Recent developments 356
11.1.3.3.1 Deals 356
11.1.3.4 MnM view 356
11.1.3.4.1 Key strengths 356
11.1.3.4.2 Strategic choices 356
11.1.3.4.3 Weaknesses & competitive threats 356
11.1.4 STRYKER 357
11.1.4.1 Business overview 357
11.1.4.2 Products offered 358
11.1.4.3 MnM view 359
11.1.4.3.1 Key strengths 359
11.1.4.3.2 Strategic choices 359
11.1.4.3.3 Weaknesses & competitive threats 359
11.1.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 360
11.1.5.1 Business overview 360
11.1.5.2 Products offered 361
11.1.5.3 Recent developments 361
11.1.5.3.1 Product launches 361
11.1.5.4 MnM view 361
11.1.5.4.1 Key strengths 361
11.1.5.4.2 Strategic choices 362
11.1.5.4.3 Weaknesses & competitive threats 362
11.1.6 CANON MEDICAL SYSTEMS CORPORATION 363
11.1.6.1 Business overview 363
11.1.6.2 Products offered 365
11.1.6.3 Recent developments 365
11.1.6.3.1 Product launches 365
11.1.6.3.2 Deals 365
11.1.7 DRÄGERWERK AG & CO. KGAA 366
11.1.7.1 Business overview 366
11.1.7.2 Products offered 367
11.1.8 NIHON KOHDEN CORPORATION 368
11.1.8.1 Business overview 368
11.1.8.2 Products offered 369
11.1.8.3 Recent developments 370
11.1.8.3.1 Deals 370
11.1.9 OLYMPUS CORPORATION 371
11.1.9.1 Business overview 371
11.1.9.2 Products offered 373
11.1.10 AVANTE HEALTH SOLUTIONS 374
11.1.10.1 Business overview 374
11.1.10.2 Products offered 375
11.1.11 SOMA TECH INTL. 376
11.1.11.1 Business overview 376
11.1.11.2 Products offered 376
11.1.12 EVERX 378
11.1.12.1 Business overview 378
11.1.12.2 Products offered 378
11.1.13 RADIOLOGY ONCOLOGY SYSTEMS 379
11.1.13.1 Business overview 379
11.1.13.2 Products offered 379
11.1.13.3 Recent developments 380
11.1.13.3.1 Deals 380
11.1.14 MASTER MEDICAL EQUIPMENT 381
11.1.14.1 Business overview 381
11.1.14.2 Products offered 381
11.1.15 FAIR-MEDICAL INC. 382
11.1.15.1 Business overview 382
11.1.15.2 Products offered 382
11.1.16 FUTURE HEALTH CONCEPTS 383
11.1.16.1 Business overview 383
11.1.16.2 Products offered 383
11.1.17 HILDITCH GROUP LTD. 384
11.1.17.1 Business overview 384
11.1.17.2 Products offered 385
11.1.18 BLOCK IMAGING, INC. 386
11.1.18.1 Business overview 386
11.1.18.2 Products offered 386
11.1.18.3 Recent developments 387
11.1.18.3.1 Deals 387
11.2 OTHER PLAYERS 388
11.2.1 NATIONWIDE IMAGING SERVICES 388
11.2.2 PACIFIC HEALTHCARE IMAGING 389
11.2.3 VENTURE MEDICAL REQUIP 390
11.2.4 DESERT TECH MEDICAL SYSTEMS INC. 391
11.2.5 HI-TECH INTERNATIONAL 392
11.2.6 AMBER DIAGNOSTICS 393
11.2.7 WHITTEMORE ENTERPRISES 394
11.2.8 TRACO MEDICAL INC. 395
11.2.9 US MED-EQUIP 396
11.2.10 US MEDICAL SYSTEMS 397
11.2.11 MEDLINE INDUSTRIES, INC. 398
11.2.12 DIRECTMED IMAGING 399
11.2.13 AGITO MEDICAL 400
12 APPENDIX 401
12.1 DISCUSSION GUIDE 401
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 407
12.3 CUSTOMIZATION OPTIONS 409
12.4 RELATED REPORTS 410
12.5 AUTHOR DETAILS 411
LIST OF TABLES
TABLE 1 REFURBISHED MEDICAL EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS 36
TABLE 2 REFURBISHED MEDICAL EQUIPMENT MARKET: STUDY ASSUMPTIONS 51
TABLE 3 REFURBISHED MEDICAL EQUIPMENT MARKET: RISK ASSESSMENT 53
TABLE 4 COMPARATIVE ANALYSIS OF AVERAGE SELLING PRICE OF NEW AND
REFURBISHED MEDICAL EQUIPMENT 65
TABLE 5 REFURBISHED MEDICAL EQUIPMENT MARKET: PORTER’S FIVE FORCES 73
TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%) 74
TABLE 7 REFURBISHED MEDICAL EQUIPMENT MARKET: LIST OF MAJOR PATENTS, 2022–2024 77
TABLE 8 REFURBISHED MEDICAL EQUIPMENT MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024–DECEMBER 2026 79
TABLE 9 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2023 (USD THOUSAND) 80
TABLE 10 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019−2023 (USD THOUSAND) 81
TABLE 11 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL EQUIPMENT,
BY REGION, 2021–2023 (USD) 83
TABLE 12 AVERAGE SELLING PRICE OF REFURBISHED MEDICAL EQUIPMENT,
BY KEY PLAYER, 2023 (USD) 88
TABLE 13 REFURBISHED MEDICAL EQUIPMENT MARKET: CURRENT UNMET NEEDS &
KEY PAIN POINTS 89
TABLE 14 REFURBISHED MEDICAL EQUIPMENT MARKET: ROLE IN ECOSYSTEM 91
TABLE 15 US: CLASSIFICATION OF REFURBISHED MEDICAL TECHNOLOGY-ASSOCIATED
MEDICAL DEVICES 96
TABLE 16 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 97
TABLE 17 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 97
TABLE 18 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 98
TABLE 19 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 99
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 100
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 100
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 101
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 101
TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 102
TABLE 25 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES, 2023 104
TABLE 26 REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 107
TABLE 27 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 109
TABLE 28 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 109
TABLE 29 NORTH AMERICA: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 30 EUROPE: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 31 ASIA PACIFIC: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY COUNTRY, 2022–2029(USD MILLION) 111
TABLE 32 LATIN AMERICA: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 33 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 112
TABLE 34 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 112
TABLE 35 REFURBISHED CT SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION) 113
TABLE 36 NORTH AMERICA: REFURBISHED CT SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 114
TABLE 37 EUROPE: REFURBISHED CT SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 114
TABLE 38 ASIA PACIFIC: REFURBISHED CT SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 115
TABLE 39 LATIN AMERICA: REFURBISHED CT SCANNERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 115
TABLE 40 MIDDLE EAST & AFRICA: REFURBISHED CT SCANNERS MARKET, BY REGION,
2022–2029 (USD MILLION) 116
TABLE 41 REFURBISHED MRI MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 42 NORTH AMERICA: REFURBISHED MRI MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 117
TABLE 43 EUROPE: REFURBISHED MRI MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 118
TABLE 44 ASIA PACIFIC: REFURBISHED MRI MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 118
TABLE 45 LATIN AMERICA: REFURBISHED MRI MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 119
TABLE 46 MIDDLE EAST & AFRICA: REFURBISHED MRI MACHINES MARKET, BY REGION,
2022–2029 (USD MILLION) 119
TABLE 47 REFURBISHED X-RAY MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 48 NORTH AMERICA: REFURBISHED X-RAY MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 120
TABLE 49 EUROPE: REFURBISHED X-RAY MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 121
TABLE 50 ASIA PACIFIC: REFURBISHED X-RAY MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 121
TABLE 51 LATIN AMERICA: REFURBISHED X-RAY MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 122
TABLE 52 MIDDLE EAST & AFRICA: REFURBISHED X-RAY MACHINES MARKET, BY REGION,
2022–2029 (USD MILLION) 122
TABLE 53 REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 123
TABLE 54 NORTH AMERICA: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 55 EUROPE: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 124
TABLE 56 ASIA PACIFIC: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 57 LATIN AMERICA: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 58 MIDDLE EAST & AFRICA: REFURBISHED NUCLEAR IMAGING SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION) 125
TABLE 59 REFURBISHED ULTRASOUND SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 126
TABLE 60 NORTH AMERICA: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 61 EUROPE: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 127
TABLE 62 ASIA PACIFIC: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 127
TABLE 63 LATIN AMERICA: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 128
TABLE 64 MIDDLE EAST & AFRICA: REFURBISHED ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 128
TABLE 65 REFURBISHED PET/SPECT SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 66 NORTH AMERICA: REFURBISHED PET/SPECT SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 129
TABLE 67 EUROPE: REFURBISHED PET/SPECT SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 130
TABLE 68 ASIA PACIFIC: REFURBISHED PET/SPECT SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 130
TABLE 69 LATIN AMERICA: REFURBISHED PET/SPECT SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 131
TABLE 70 MIDDLE EAST & AFRICA: REFURBISHED PET/SPECT SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 131
TABLE 71 REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 132
TABLE 72 NORTH AMERICA: REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 73 EUROPE: REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 133
TABLE 74 ASIA PACIFIC: REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 75 LATIN AMERICA: REFURBISHED MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 76 MIDDLE EAST & AFRICA: REFURBISHED MAMMOGRAPHY SYETMS MARKET,
BY REGION, 2022–2029 (USD MILLION) 134
TABLE 77 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 135
TABLE 78 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 79 NORTH AMERICA: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 80 EUROPE: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 81 ASIA PACIFIC: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 82 LATIN AMERICA: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 83 MIDDLE EAST & AFRICA: REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 138
TABLE 84 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 138
TABLE 85 REFURBISHED ANESTHESIA MACHINES MARKET, BY REGION,
2022–2029 (USD MILLION) 139
TABLE 86 NORTH AMERICA: REFURBISHED ANESTHESIA MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 87 EUROPE: REFURBISHED ANESTHESIA MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 140
TABLE 88 ASIA PACIFIC: REFURBISHED ANESTHESIA MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 140
TABLE 89 LATIN AMERICA: REFURBISHED ANESTHESIA MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 90 MIDDLE EAST & AFRICA: REFURBISHED ANESTHESIA MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 141
TABLE 91 REFURBISHED ELECTROSURGICAL UNITS MARKET, BY REGION,
2022–2029 (USD MILLION) 142
TABLE 92 NORTH AMERICA: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 93 EUROPE: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 143
TABLE 94 ASIA PACIFIC: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 143
TABLE 95 LATIN AMERICA: REFURBISHED ELECTROSURGICAL UNITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 96 MIDDLE EAST & AFRICA: REFURBISHED ELECTROSURGICAL UNITS MARKET,
BY REGION, 2022–2029 (USD MILLION) 144
TABLE 97 REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY REGION,
2022–2029 (USD MILLION) 145
TABLE 98 NORTH AMERICA: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 99 EUROPE: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 100 ASIA PACIFIC: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 101 LATIN AMERICA: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 102 MIDDLE EAST & AFRICA: REFURBISHED OPERATING ROOM TABLES & LIGHTS MARKET, BY REGION, 2022–2029 (USD MILLION) 147
TABLE 103 REFURBISHED SURGICAL DISPLAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 148
TABLE 104 NORTH AMERICA: REFURBISHED SURGICAL DISPLAYS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 149
TABLE 105 EUROPE: REFURBISHED SURGICAL DISPLAYS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 149
TABLE 106 ASIA PACIFIC: REFURBISHED SURGICAL DISPLAYS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 150
TABLE 107 LATIN AMERICA: REFURBISHED SURGICAL DISPLAYS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 150
TABLE 108 MIDDLE EAST & AFRICA: REFURBISHED SURGICAL DISPLAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 151
TABLE 109 OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 151
TABLE 110 NORTH AMERICA: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 111 EUROPE: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 112 ASIA PACIFIC: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029(USD MILLION) 153
TABLE 113 LATIN AMERICA: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 114 MIDDLE EAST & AFRICA: OTHER REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 154
TABLE 115 REFURBISHED PATIENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 155
TABLE 116 REFURBISHED PATIENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 155
TABLE 117 NORTH AMERICA: REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 156
TABLE 118 EUROPE: REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 156
TABLE 119 ASIA PACIFIC: REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 157
TABLE 120 LATIN AMERICA: REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 157
TABLE 121 MIDDLE EAST & AFRICA: REFURBISHED PATIENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 122 REFURBISHED PATIENT MONITORS MARKET, BY END USER,
2022–2029 (USD MILLION) 158
TABLE 123 REFURBISHED MULTIPARAMETER MONITORS MARKET, BY REGION,
2022–2029 (USD MILLION) 159
TABLE 124 NORTH AMERICA: REFURBISHED MULTIPARAMETER MONITORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 125 EUROPE: REFURBISHED MULTIPARAMETER MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 160
TABLE 126 ASIA PACIFIC: REFURBISHED MULTIPARAMETER MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 127 LATIN AMERICA: REFURBISHED MULTIPARAMETER MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 128 MIDDLE EAST & AFRICA: REFURBISHED MULTIPARAMETER MONITORS MARKET,
BY REGION, 2022–2029 (USD MILLION) 162
TABLE 129 REFURBISHED FETAL MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 163
TABLE 130 NORTH AMERICA: REFURBISHED FETAL MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 163
TABLE 131 EUROPE: REFURBISHED FETAL MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 164
TABLE 132 ASIA PACIFIC: REFURBISHED FETAL MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 164
TABLE 133 LATIN AMERICA: REFURBISHED FETAL MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 165
TABLE 134 MIDDLE EAST & AFRICA: REFURBISHED FETAL MONITORS MARKET, BY REGION,
2022–2029 (USD MILLION) 165
TABLE 135 REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 167
TABLE 136 NORTH AMERICA: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 137 EUROPE: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 138 ASIA PACIFIC: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 139 LATIN AMERICA: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 140 MIDDLE EAST & AFRICA: REFURBISHED ELECTROCARDIOGRAPHY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 169
TABLE 141 REFURBISHED PULSE OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 170
TABLE 142 NORTH AMERICA: REFURBISHED PULSE OXIMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 171
TABLE 143 EUROPE: REFURBISHED PULSE OXIMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 171
TABLE 144 ASIA PACIFIC: REFURBISHED PULSE OXIMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 172
TABLE 145 LATIN AMERICA: REFURBISHED PULSE OXIMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 172
TABLE 146 MIDDLE EAST & AFRICA: REFURBISHED PULSE OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 147 REFURBISHED CARDIAC MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 174
TABLE 148 NORTH AMERICA: REFURBISHED CARDIAC MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 174
TABLE 149 EUROPE: REFURBISHED CARDIAC MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 175
TABLE 150 ASIA PACIFIC: REFURBISHED CARDIAC MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 175
TABLE 151 LATIN AMERICA: REFURBISHED CARDIAC MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 176
TABLE 152 MIDDLE EAST & AFRICA: REFURBISHED CARDIAC MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 176
TABLE 153 REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 177
TABLE 154 NORTH AMERICA: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 155 EUROPE: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 156 ASIA PACIFIC: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 157 LATIN AMERICA: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 158 MIDDLE EAST & AFRICA: REFURBISHED NON-INVASIVE BLOOD PRESSURE MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 179
TABLE 159 OTHER REFURBISHED PATIENT MONITORS MARKET, BY REGION,
2022–2029 (USD MILLION) 180
TABLE 160 NORTH AMERICA: OTHER REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 161 EUROPE: OTHER REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 181
TABLE 162 ASIA PACIFIC: OTHER REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 163 LATIN AMERICA: OTHER REFURBISHED PATIENT MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 164 MIDDLE EAST & AFRICA: OTHER REFURBISHED PATIENT MONITORS MARKET,
BY REGION, 2022–2029 (USD MILLION) 183
TABLE 165 REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 183
TABLE 166 REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 184
TABLE 167 NORTH AMERICA: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 168 EUROPE: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 185
TABLE 169 ASIA PACIFIC: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 185
TABLE 170 LATIN AMERICA: REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 171 MIDDLE EAST & AFRICA: REFURBISHED CARDIOLOGY EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 186
TABLE 172 REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 187
TABLE 173 REFURBISHED DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 188
TABLE 174 NORTH AMERICA: REFURBISHED DEFIBRILLATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 188
TABLE 175 EUROPE: REFURBISHED DEFIBRILLATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 189
TABLE 176 ASIA PACIFIC: REFURBISHED DEFIBRILLATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 189
TABLE 177 LATIN AMERICA: REFURBISHED DEFIBRILLATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 190
TABLE 178 MIDDLE EAST & AFRICA: REFURBISHED DEFIBRILLATORS MARKET, BY REGION,
2022–2029 (USD MILLION) 190
TABLE 179 REFURBISHED HEART-LUNG MACHINES MARKET, BY REGION,
2022–2029 (USD MILLION) 191
TABLE 180 NORTH AMERICA: REFURBISHED HEART-LUNG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 181 EUROPE: REFURBISHED HEART-LUNG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 192
TABLE 182 ASIA PACIFIC: REFURBISHED HEART-LUNG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 192
TABLE 183 LATIN AMERICA: REFURBISHED HEART-LUNG MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 184 MIDDLE EAST & AFRICA: REFURBISHED HEART-LUNG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 193
TABLE 185 OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 194
TABLE 186 NORTH AMERICA: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 187 EUROPE: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195
TABLE 188 ASIA PACIFIC: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195
TABLE 189 LATIN AMERICA: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 190 MIDDLE EAST & AFRICA: OTHER REFURBISHED CARDIOLOGY EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 196
TABLE 191 REFURBISHED UROLOGY EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 192 REFURBISHED UROLOGY EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 197
TABLE 193 NORTH AMERICA: REFURBISHED UROLOGY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 198
TABLE 194 EUROPE: REFURBISHED UROLOGY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 198
TABLE 195 ASIA PACIFIC: REFURBISHED UROLOGY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 199
TABLE 196 LATIN AMERICA: REFURBISHED UROLOGY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 199
TABLE 197 MIDDLE EAST & AFRICA: REFURBISHED UROLOGY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 200
TABLE 198 REFURBISHED UROLOGY EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 200
TABLE 199 REFURBISHED DIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 201
TABLE 200 NORTH AMERICA: REFURBISHED DIALYSIS MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 201
TABLE 201 EUROPE: REFURBISHED DIALYSIS MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 202
TABLE 202 ASIA PACIFIC: REFURBISHED DIALYSIS MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 202
TABLE 203 LATIN AMERICA: REFURBISHED DIALYSIS MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 203
TABLE 204 MIDDLE EAST & AFRICA: REFURBISHED DIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 205 REFURBISHED LITHOTRIPSY DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 204
TABLE 206 NORTH AMERICA: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 204
TABLE 207 EUROPE: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 205
TABLE 208 ASIA PACIFIC: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 205
TABLE 209 LATIN AMERICA: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 206
TABLE 210 MIDDLE EAST & AFRICA: REFURBISHED LITHOTRIPSY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 206
TABLE 211 REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 207
TABLE 212 REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 207
TABLE 213 NORTH AMERICA: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 214 EUROPE: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 208
TABLE 215 ASIA PACIFIC: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 209
TABLE 216 LATIN AMERICA: REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 217 MIDDLE EAST & AFRICA: REFURBISHED NEUROLOGY EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 210
TABLE 218 REFURBISHED NEUROLOGY EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 210
TABLE 219 REFURBISHED EMG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 211
TABLE 220 NORTH AMERICA: REFURBISHED EMG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 211
TABLE 221 EUROPE: REFURBISHED EMG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 212
TABLE 222 ASIA PACIFIC: REFURBISHED EMG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 212
TABLE 223 LATIN AMERICA: REFURBISHED EMG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 213
TABLE 224 MIDDLE EAST & AFRICA: REFURBISHED EMG MACHINES MARKET, BY REGION,
2022–2029 (USD MILLION) 213
TABLE 225 REFURBISHED EEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 214
TABLE 226 NORTH AMERICA: REFURBISHED EEG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 214
TABLE 227 EUROPE: REFURBISHED EEG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 215
TABLE 228 ASIA PACIFIC: REFURBISHED EEG MACHINES MARKET, BY COUNTRY,
2022–2029(USD MILLION) 215
TABLE 229 LATIN AMERICA: REFURBISHED EEG MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 216
TABLE 230 MIDDLE EAST & AFRICA: REFURBISHED EEG MACHINES MARKET, BY REGION,
2022–2029 (USD MILLION) 216
TABLE 231 REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY TYPE,
2022–2029 (USD MILLION) 217
TABLE 232 REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 217
TABLE 233 NORTH AMERICA: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 234 EUROPE: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 218
TABLE 235 ASIA PACIFIC: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 236 LATIN AMERICA: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 237 MIDDLE EAST & AFRICA: REFURBISHED INTENSIVE CARE EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 220
TABLE 238 REFURBISHED MEDICAL EQUIPMENT MARKET FOR INTENSIVE CARE EQUIPMENT,
BY END USER, 2022–2029 (USD MILLION) 220
TABLE 239 REFURBISHED VENTILATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 221
TABLE 240 NORTH AMERICA: REFURBISHED VENTILATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 222
TABLE 241 EUROPE: REFURBISHED VENTILATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 222
TABLE 242 ASIA PACIFIC: REFURBISHED VENTILATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 223
TABLE 243 LATIN AMERICA: REFURBISHED VENTILATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 223
TABLE 244 MIDDLE EAST & AFRICA: REFURBISHED VENTILATORS MARKET, BY REGION,
2022–2029 (USD MILLION) 224
TABLE 245 REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY REGION,
2022–2029 (USD MILLION) 225
TABLE 246 NORTH AMERICA: REFURBISHED INFANT INCUBATORS & WARMERS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 247 EUROPE: REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 226
TABLE 248 ASIA PACIFIC: REFURBISHED INFANT INCUBATORS & WARMERS MARKET,
BY COUNTRY, 2022–2029(USD MILLION) 226
TABLE 249 LATIN AMERICA: REFURBISHED INFANT INCUBATORS & WARMERS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 227
TABLE 250 MIDDLE EAST & AFRICA: REFURBISHED INFANT INCUBATORS & WARMERS MARKET, BY REGION, 2022–2029 (USD MILLION) 227
TABLE 251 REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 229
TABLE 252 NORTH AMERICA: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 229
TABLE 253 EUROPE: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 254 ASIA PACIFIC: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 255 LATIN AMERICA: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 231
TABLE 256 MIDDLE EAST & AFRICA: REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 231
TABLE 257 REFURBISHED INTRAVENOUS THERAPY SYSTEMS MARKET, BY END USER,
2022–2029 (USD MILLION) 232
TABLE 258 REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 233
TABLE 259 NORTH AMERICA: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 260 EUROPE: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 234
TABLE 261 ASIA PACIFIC: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 234
TABLE 262 LATIN AMERICA: REFURBISHED ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 235
TABLE 263 MIDDLE EAST & AFRICA: REFURBISHED ENDOSCOPY EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 235
TABLE 264 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ENDOSCOPY EQUIPMENT,
BY END USER, 2022–2029 (USD MILLION) 236
TABLE 265 OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 237
TABLE 266 NORTH AMERICA: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 237
TABLE 267 EUROPE: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 238
TABLE 268 ASIA PACIFIC: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 238
TABLE 269 LATIN AMERICA: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 239
TABLE 270 MIDDLE EAST & AFRICA: OTHER REFURBISHED MEDICAL EQUIPMENT MARKET,
BY REGION, 2022–2029 (USD MILLION) 239
TABLE 271 OTHER REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 240
TABLE 272 REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 243
TABLE 273 REFURBISHED MEDICAL EQUIPMENT MARKET FOR CARDIOLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 244
TABLE 274 REFURBISHED MEDICAL EQUIPMENT MARKET FOR UROLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 245
TABLE 275 REFURBISHED MEDICAL EQUIPMENT MARKET FOR NEUROLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 246
TABLE 276 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ORTHOPEDIC DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 247
TABLE 277 REFURBISHED MEDICAL EQUIPMENT MARKET FOR PHYSIOLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 248
TABLE 278 REFURBISHED MEDICAL EQUIPMENT MARKET FOR EMERGENCY MEDICINE DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 249
TABLE 279 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ONCOLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 250
TABLE 280 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OB/GYNECOLOGY DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 251
TABLE 281 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 252
TABLE 282 REFURBISHED MEDICAL EQUIPMENT MARKET FOR CARDIOLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 253
TABLE 283 REFURBISHED MEDICAL EQUIPMENT MARKET FOR UROLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 254
TABLE 284 REFURBISHED MEDICAL EQUIPMENT MARKET FOR NEUROLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 255
TABLE 285 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ORTHOPEDIC THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 256
TABLE 286 REFURBISHED MEDICAL EQUIPMENT MARKET FOR PHYSIOLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 257
TABLE 287 REFURBISHED MEDICAL EQUIPMENT MARKET FOR EMERGENCY MEDICINE THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 258
TABLE 288 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ONCOLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 259
TABLE 289 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OB/GYNECOLOGY THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 260
TABLE 290 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 260
TABLE 291 REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 262
TABLE 292 REFURBISHED MEDICAL EQUIPMENT MARKET FOR HOSPITALS, BY REGION,
2022–2029 (USD MILLION) 263
TABLE 293 REFURBISHED MEDICAL EQUIPMENT MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022–2029 (USD MILLION) 264
TABLE 294 REFURBISHED MEDICAL EQUIPMENT MARKET FOR ACADEMIC & GOVERNMENT ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION) 265
TABLE 295 REFURBISHED MEDICAL EQUIPMENT MARKET FOR AMBULATORY CARE CENTERS,
BY REGION, 2022–2029 (USD MILLION) 266
TABLE 296 REFURBISHED MEDICAL EQUIPMENT MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 267
TABLE 297 REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 269
TABLE 298 NORTH AMERICA: KEY MACROINDICATORS 270
TABLE 299 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 272
TABLE 300 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 272
TABLE 301 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 273
TABLE 302 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 274
TABLE 303 US: KEY MACROINDICATORS 275
TABLE 304 US: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 275
TABLE 305 CANADA: KEY MACROINDICATORS 276
TABLE 306 CANADA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 277
TABLE 307 EUROPE: KEY MACROINDICATORS 278
TABLE 308 EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 279
TABLE 309 EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 280
TABLE 310 EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 281
TABLE 311 EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 282
TABLE 312 GERMANY: KEY MACROINDICATORS 283
TABLE 313 GERMANY: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 283
TABLE 314 FRANCE: KEY MACROINDICATORS 284
TABLE 315 FRANCE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 285
TABLE 316 UK: KEY MACROINDICATORS 286
TABLE 317 UK: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 286
TABLE 318 ITALY: KEY MACROINDICATORS 287
TABLE 319 ITALY: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 288
TABLE 320 SPAIN: KEY MACROINDICATORS 289
TABLE 321 SPAIN: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 289
TABLE 322 REST OF EUROPE: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 290
TABLE 323 ASIA PACIFIC: KEY MACROINDICATORS 292
TABLE 324 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 294
TABLE 325 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 295
TABLE 326 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 296
TABLE 327 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 297
TABLE 328 CHINA: KEY MACROINDICATORS 298
TABLE 329 CHINA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 298
TABLE 330 JAPAN: KEY MACROINDICATORS 299
TABLE 331 JAPAN: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 300
TABLE 332 INDIA: KEY MACROINDICATORS 301
TABLE 333 INDIA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 301
TABLE 334 AUSTRALIA: KEY MACROINDICATORS 302
TABLE 335 AUSTRALIA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 303
TABLE 336 SOUTH KOREA: KEY MACROINDICATORS 304
TABLE 337 SOUTH KOREA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 304
TABLE 338 REST OF ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 305
TABLE 339 LATIN AMERICA: KEY MACROINDICATORS 306
TABLE 340 LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 306
TABLE 341 LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 307
TABLE 342 LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 308
TABLE 343 LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER,
2022–2029 (USD MILLION) 309
TABLE 344 BRAZIL: KEY MACROINDICATORS 310
TABLE 345 BRAZIL: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 310
TABLE 346 MEXICO: KEY MACROINDICATORS 311
TABLE 347 MEXICO: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 312
TABLE 348 REST OF LATIN AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 313
TABLE 349 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 314
TABLE 350 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 315
TABLE 351 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 315
TABLE 352 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 316
TABLE 353 MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION) 317
TABLE 354 GCC COUNTRIES: REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 318
TABLE 355 REST OF MIDDLE EAST & AFRICA: REFURBISHED MEDICAL EQUIPMENT MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 319
TABLE 356 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN REFURBISHED MEDICAL EQUIPMENT MARKET 320
TABLE 357 REFURBISHED MEDICAL EQUIPMENT MARKET: DEGREE OF COMPETITION 325
TABLE 358 REFURBISHED MEDICAL EQUIPMENT MARKET: REGION FOOTPRINT 329
TABLE 359 REFURBISHED MEDICAL EQUIPMENT MARKET: PRODUCT FOOTPRINT 330
TABLE 360 REFURBISHED MEDICAL EQUIPMENT MARKET: APPLICATION FOOTPRINT 331
TABLE 361 REFURBISHED MEDICAL EQUIPMENT MARKET: END-USER FOOTPRINT 332
TABLE 362 REFURBISHED MEDICAL EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 335
TABLE 363 REFURBISHED MEDICAL EQUIPMENT MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES 336
TABLE 364 REFURBISHED MEDICAL EQUIPMENT MARKET: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 339
TABLE 365 REFURBISHED MEDICAL EQUIPMENT MARKET: DEALS, JANUARY 2021–
NOVEMBER 2024 340
TABLE 366 GE HEALTHCARE: COMPANY OVERVIEW 341
TABLE 367 GE HEALTHCARE: PRODUCTS OFFERED 343
TABLE 368 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 345
TABLE 369 GE HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 345
TABLE 370 GE HEALTHCARE: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 345
TABLE 371 PHILIPS HEALTHCARE: COMPANY OVERVIEW 347
TABLE 372 PHILIPS HEALTHCARE: PRODUCTS OFFERED 348
TABLE 373 PHILIPS HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 350
TABLE 374 PHILIPS HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 351
TABLE 375 PHILIPS HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 351
TABLE 376 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 353
TABLE 377 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 354
TABLE 378 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–NOVEMBER 2024 356
TABLE 379 STRYKER: COMPANY OVERVIEW 357
TABLE 380 STRYKER: PRODUCTS OFFERED 358
TABLE 381 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 360
TABLE 382 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 361
TABLE 383 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 361
TABLE 384 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 363
TABLE 385 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 365
TABLE 386 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 365
TABLE 387 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 365
TABLE 388 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 366
TABLE 389 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 367
TABLE 390 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 368
TABLE 391 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 369
TABLE 392 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 370
TABLE 393 OLYMPUS CORPORATION.: COMPANY OVERVIEW 371
TABLE 394 OLYMPUS CORPORATION: PRODUCTS OFFERED 373
TABLE 395 AVANTE HEALTH SOLUTIONS: COMPANY OVERVIEW 374
TABLE 396 AVANTE HEALTH SOLUTIONS: PRODUCTS OFFERED 375
TABLE 397 SOMA TECH INTL.: COMPANY OVERVIEW 376
TABLE 398 SOMA TECH INTL.: PRODUCTS OFFERED 376
TABLE 399 EVERX: COMPANY OVERVIEW 378
TABLE 400 EVERX: PRODUCTS OFFERED 378
TABLE 401 RADIOLOGY ONCOLOGY SYSTEMS: COMPANY OVERVIEW 379
TABLE 402 RADIOLOGY ONCOLOGY SYSTEMS: PRODUCTS OFFERED 379
TABLE 403 RADIOLOGY ONCOLOGY SYSTEMS: DEALS, JANUARY 2021–NOVEMBER 2024 380
TABLE 404 MASTER MEDICAL EQUIPMENT: COMPANY OVERVIEW 381
TABLE 405 MASTER MEDICAL EQUIPMENT: PRODUCTS OFFERED 381
TABLE 406 FAIR-MEDICAL INC.: COMPANY OVERVIEW 382
TABLE 407 FAIR-MEDICAL INC.: PRODUCTS OFFERED 382
TABLE 408 FUTURE HEALTH CONCEPTS: COMPANY OVERVIEW 383
TABLE 409 FUTURE HEALTH CONCEPTS: PRODUCTS OFFERED 383
TABLE 410 HILDITCH GROUP LTD.: COMPANY OVERVIEW 384
TABLE 411 HILDITCH GROUP LTD.: PRODUCTS OFFERED 385
TABLE 412 BLOCK IMAGING, INC.: COMPANY OVERVIEW 386
TABLE 413 BLOCK IMAGING, INC.: PRODUCTS OFFERED 386
TABLE 414 BLOCK IMAGING, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 387
TABLE 415 NATIONWIDE IMAGING SERVICES: COMPANY OVERVIEW 388
TABLE 416 PACIFIC HEALTHCARE IMAGING: COMPANY OVERVIEW 389
TABLE 417 VENTURE MEDICAL REQUIP: COMPANY OVERVIEW 390
TABLE 418 DESERT TECH MEDICAL SYSTEMS INC.: COMPANY OVERVIEW 391
TABLE 419 HI-TECH INTERNATIONAL: COMPANY OVERVIEW 392
TABLE 420 AMBER DIAGNOSTICS: COMPANY OVERVIEW 393
TABLE 421 WHITTEMORE ENTERPRISES: COMPANY OVERVIEW 394
TABLE 422 TRACO MEDICAL INC.: COMPANY OVERVIEW 395
TABLE 423 US MED-EQUIP: COMPANY OVERVIEW 396
TABLE 424 US MEDICAL SYSTEMS: COMPANY OVERVIEW 397
TABLE 425 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW 398
TABLE 426 DIRECTMED IMAGING: COMPANY OVERVIEW 399
TABLE 427 AGITO MEDICAL: COMPANY OVERVIEW 400
LIST OF FIGURES
FIGURE 1 REFURBISHED MEDICAL EQUIPMENT MARKET: SEGMENTS COVERED & GEOGRAPHICAL SPREAD 35
FIGURE 2 REFURBISHED MEDICAL EQUIPMENT MARKET: YEARS CONSIDERED 37
FIGURE 3 REFURBISHED MEDICAL EQUIPMENT MARKET: RESEARCH DATA 39
FIGURE 4 REFURBISHED MEDICAL EQUIPMENT MARKET: RESEARCH DESIGN 40
FIGURE 5 REFURBISHED MEDICAL EQUIPMENT MARKET: KEY DATA FROM SECONDARY SOURCES 42
FIGURE 6 REFURBISHED MEDICAL EQUIPMENT MARKET: KEY PRIMARY SOURCES 43
FIGURE 7 REFURBISHED MEDICAL EQUIPMENT MARKET: KEY INDUSTRY INSIGHTS 44
FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 44
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 45
FIGURE 10 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 46
FIGURE 11 REFURBISHED MEDICAL EQUIPMENT MARKET SIZE ESTIMATION:
COMPANY REVENUE ESTIMATION 47
FIGURE 12 REFURBISHED MEDICAL EQUIPMENT MARKET SIZE ESTIMATION:
BOTTOM-UP APPROACH 48
FIGURE 13 REFURBISHED MEDICAL EQUIPMENT MARKET: TOP-DOWN APPROACH 48
FIGURE 14 REFURBISHED MEDICAL EQUIPMENT MARKET: DATA TRIANGULATION 50
FIGURE 15 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS 52
FIGURE 16 REFURBISHED MEDICAL EQUIPMENT MARKET, BY PRODUCT,
2024 VS. 2029 (USD MILLION) 56
FIGURE 17 REFURBISHED MEDICAL EQUIPMENT MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 57
FIGURE 18 REFURBISHED MEDICAL EQUIPMENT MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 58
FIGURE 19 REGIONAL SNAPSHOT OF REFURBISHED MEDICAL EQUIPMENT MARKET 59
FIGURE 20 INCREASING DEMAND FOR ADVANCED REFURBISHED MEDICAL EQUIPMENT
TO DRIVE MARKET 60
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61
FIGURE 22 US AND ACADEMIC & GOVERNMENT ORGANIZATIONS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 62
FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029 63
FIGURE 24 REFURBISHED MEDICAL EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
FIGURE 25 REFURBISHED MEDICAL EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 71
FIGURE 26 REFURBISHED MEDICAL EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 72
FIGURE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 74
FIGURE 28 KEY BUYING CRITERIA FOR TOP FOUR END USERS 75
FIGURE 29 PATENT ANALYSIS FOR REFURBISHED MEDICAL EQUIPMENT
(JANUARY 2014–AUGUST 2024) 76
FIGURE 30 AVERAGE SELLING PRICE TREND OF REFURBISHED MEDICAL IMAGING EQUIPMENT,
BY PRODUCT, 2021–2023 (USD) 85
FIGURE 31 AVERAGE SELLING PRICE TREND OF REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT, BY PRODUCT, 2021–2023 (USD) 86
FIGURE 32 AVERAGE SELLING PRICE TREND OF REFURBISHED PATIENT MONITORS,
BY PRODUCT, 2021–2023 (USD) 86
FIGURE 33 AVERAGE SELLING PRICE TREND OF OTHER REFURBISHED MEDICAL EQUIPMENT,
BY PRODUCT, 2021–2023 (USD) 87
FIGURE 34 AVERAGE SELLING PRICE OF REFURBISHED MEDICAL EQUIPMENT,
BY KEY PLAYER, 2023 (USD) 88
FIGURE 35 REFURBISHED MEDICAL EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 90
FIGURE 36 REFURBISHED MEDICAL EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 92
FIGURE 37 REFURBISHED MEDICAL EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93
FIGURE 38 REFURBISHED MEDICAL EQUIPMENT MARKET: INVESTMENT &
FUNDING SCENARIO, 2019–2023 102
FIGURE 39 REFURBISHED MEDICAL EQUIPMENT MARKET: NUMBER OF INVESTOR DEALS,
BY KEY PLAYER, 2019–2023 103
FIGURE 40 REFURBISHED MEDICAL EQUIPMENT MARKET: DEAL VALUE, BY KEY PLAYER,
2019–2023 (USD MILLION) 103
FIGURE 41 REFURBISHED MEDICAL EQUIPMENT MARKET: IMPACT OF AI/GEN AI 105
FIGURE 42 NORTH AMERICA: REFURBISHED MEDICAL EQUIPMENT MARKET SNAPSHOT 271
FIGURE 43 ASIA PACIFIC: REFURBISHED MEDICAL EQUIPMENT MARKET SNAPSHOT 293
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN REFURBISHED MEDICAL
EQUIPMENT MARKET (2019–2023) 322
FIGURE 45 REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET SHARE (2023) 323
FIGURE 46 REFURBISHED OPERATING ROOM & SURGICAL EQUIPMENT MARKET SHARE (2023) 323
FIGURE 47 REFURBISHED PATIENT MONITORS MARKET SHARE (2023) 324
FIGURE 48 REFURBISHED MEDICAL EQUIPMENT MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 327
FIGURE 49 REFURBISHED MEDICAL EQUIPMENT MARKET: COMPANY FOOTPRINT 328
FIGURE 50 REFURBISHED MEDICAL EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 334
FIGURE 51 EV/EBITDA OF KEY VENDORS 337
FIGURE 52 5-YEAR STOCK BETA OF KEY VENDORS 337
FIGURE 53 REFURBISHED MEDICAL EQUIPMENT MARKET:
BRAND/PRODUCT COMPARATIVE ANALYSIS 338
FIGURE 54 GE HEALTHCARE: COMPANY SNAPSHOT 342
FIGURE 55 PHILIPS HEALTHCARE: COMPANY SNAPSHOT 348
FIGURE 56 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 354
FIGURE 57 STRYKER: COMPANY SNAPSHOT 358
FIGURE 58 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT 360
FIGURE 59 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 364
FIGURE 60 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT 367
FIGURE 61 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 369
FIGURE 62 OLYMPUS CORPORATION: COMPANY SNAPSHOT 372
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11